LakeShore Biopharma Co., Ltd (LSB)
NASDAQ: LSB · Real-Time Price · USD
2.570
+0.040 (1.58%)
Nov 21, 2024, 4:00 PM EST - Market closed
LakeShore Biopharma Cash Flow Statement
Financials in millions CNY. Fiscal year is April - March.
Millions CNY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| Net Income | -433.46 | -433.46 | -283.47 | -236.67 | -208.44 |
| Depreciation & Amortization | 42.19 | 42.19 | 36.69 | 31.15 | 27.91 |
| Loss (Gain) From Sale of Assets | 0.01 | 0.01 | - | 0.27 | 0.02 |
| Asset Writedown & Restructuring Costs | 80.24 | 80.24 | - | - | - |
| Stock-Based Compensation | 9.79 | 9.79 | 3.51 | 7.76 | 76.76 |
| Provision & Write-off of Bad Debts | 4.99 | 4.99 | 10.75 | 5.08 | 6.41 |
| Other Operating Activities | 46.81 | 46.81 | 142.8 | 143.78 | 37.41 |
| Change in Accounts Receivable | 13.9 | 13.9 | -165.25 | -99.14 | -220.73 |
| Change in Inventory | -86.26 | -86.26 | -18.15 | -89.46 | -68.73 |
| Change in Accounts Payable | -12.66 | -12.66 | 49.63 | 14.43 | -4.42 |
| Change in Unearned Revenue | -3.61 | -3.61 | -6.45 | -0.66 | -0.04 |
| Change in Income Taxes | - | - | - | - | -34.11 |
| Change in Other Net Operating Assets | 42.84 | 42.84 | 47.47 | 49.89 | 141.35 |
| Operating Cash Flow | -295.23 | -295.23 | -182.47 | -173.55 | -246.61 |
| Capital Expenditures | -44.25 | -44.25 | -52.76 | -295.31 | -104.88 |
| Sale of Property, Plant & Equipment | - | - | 0.07 | 0.01 | 0.64 |
| Sale (Purchase) of Intangibles | - | - | -4.29 | -3.62 | - |
| Investing Cash Flow | -44.25 | -44.25 | -56.98 | -298.92 | -104.24 |
| Short-Term Debt Issued | - | - | - | - | 299.76 |
| Long-Term Debt Issued | 337.85 | 337.85 | 247.39 | 414.12 | 32.25 |
| Total Debt Issued | 337.85 | 337.85 | 247.39 | 414.12 | 332.01 |
| Short-Term Debt Repaid | - | - | - | - | -163.35 |
| Long-Term Debt Repaid | -416.79 | -416.79 | -146.51 | -49.56 | -160.41 |
| Total Debt Repaid | -416.79 | -416.79 | -146.51 | -49.56 | -323.75 |
| Net Debt Issued (Repaid) | -78.93 | -78.93 | 100.88 | 364.56 | 8.26 |
| Issuance of Common Stock | 284.2 | 284.2 | - | - | 1.59 |
| Other Financing Activities | - | - | 216.57 | - | - |
| Financing Cash Flow | 205.26 | 205.26 | 317.45 | 364.56 | 739.26 |
| Foreign Exchange Rate Adjustments | 10.4 | 10.4 | 21.3 | -11.48 | -0 |
| Net Cash Flow | -123.82 | -123.82 | 99.3 | -119.39 | 388.41 |
| Free Cash Flow | -339.48 | -339.48 | -235.23 | -468.86 | -351.49 |
| Free Cash Flow Margin | -59.20% | -59.20% | -34.23% | -93.22% | -136.76% |
| Free Cash Flow Per Share | -31.75 | -31.75 | -38.07 | -75.83 | -56.85 |
| Cash Interest Paid | 30.13 | 30.13 | 27.29 | 2.4 | 8.12 |
| Cash Income Tax Paid | - | - | - | - | 34.11 |
| Levered Free Cash Flow | -216.49 | -216.49 | -189.61 | -465.23 | - |
| Unlevered Free Cash Flow | -188.77 | -188.77 | -170.32 | -463.53 | - |
| Change in Net Working Capital | -27.31 | -27.31 | 71.76 | 132.35 | - |
Source: S&P Capital IQ. Standard template. Financial Sources.